BRAF inhibitor: a novel therapy for ameloblastoma in mandible

Chin J Cancer Res. 2018 Dec;30(6):677-678. doi: 10.21147/j.issn.1000-9604.2018.06.12.

Masanobu Abe^{1

2}, Liang Zong^{3

4}, Takahiro Abe¹, Hideyuki Takeshima⁵, Jiafu Ji³, Toshikazu Ushijima⁵, Kazuto Hoshi¹

¹ Department of Oral & Maxillofacial Surgery, University of Tokyo Hospital, Tokyo 113-8655, Japan.
² Division for Health Service Promotion, University of Tokyo, Tokyo 113-8655, Japan.
³ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
⁴ Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
⁵ Division of Epigenomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.

No abstract available